Navigation Links
Generx DNA-Based Angiogenic Therapy Receives Russian Ministry of Health Clearance for Late-Stage Registration Clinical Study for Coronary Artery Disease
Date:6/15/2011

SAN DIEGO, June 15, 2011 /PRNewswire/ -- Cardium Therapeutics (NYSE Amex: CXM) today announced that it has received clearance from the Russian Ministry of Health and Social Development to commence a Phase 3 registration study for the Company's Generx™ (alferminogene tadenovec, Ad5FGF-4) biologic product candidate.  Generx is a new and innovative DNA-based angiogenic therapy designed for the potential treatment of myocardial ischemia due to coronary artery disease. The Russian Health Authority has assigned Generx the therapeutic drug trade name of Cardionovo™ for marketing and sales in Russia.  The new YouTube video "Cardium Generx Cardio-Chant" provides an overview of the Company's Generx product candidate, at http://www.youtube.com/watch?v=pjUndFhJkjM.

(Photo: http://photos.prnewswire.com/prnh/20110615/LA20238)

(Logo: http://photos.prnewswire.com/prnh/20051018/CARDIUMLOGO)

This newly approved clinical study (ASPIRE) is a randomized, controlled, parallel group, multi-center study designed to evaluate the safety and efficacy of Cardium's Generx product candidate using SPECT imaging to measure improvements in microvascular cardiac perfusion following a one-time, non-surgical, catheter-based administration of Generx DNA-based angiogenic therapy.  As designed, the ASPIRE clinical study is expected to enroll approximately 100 men and women with myocardial ischemia due to coronary artery disease at up to three leading medical centers in Moscow.  The study's primary efficacy endpoint will be the improvement in reversible perfusion defect size as measured by SPECT imaging.

The ASPIRE study will represent the fifth clinical study under Generx's
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Cardium Announces Appointment of Paul A. Foster, M.D. to Lead Generx and Excellarate Late-Stage Development Activities
2. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
3. deCODE Launches a DNA-Based Test for Assessing Risk of Prostate Cancer on the Back of the Discovery of New Prostate Cancer Genes
4. SF1126, Semafores PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines
5. Clinical Experience With Peregrines Anti-Cancer Agent Bavituximab Presented at Leading Symposium on Anti-Angiogenic Agents
6. Semafores SF1126 Exhibits Antitumor and Antiangiogenic Activity
7. Multiple Presentations Confirm Clinical Efficacy and High Rate of Patient Compliance Using Provent® Sleep Apnea Therapy to Treat Obstructive Sleep Apnea
8. Dry Eye Therapy Utilizing Cationic Novasorb® Technology Available Soon From OCuSOFT®
9. Accuray Successfully Completes Acquisition of TomoTherapy
10. Vertex Plans to Provide Access to Potential CF Therapy VX-770 for Patients with Critical Medical Need
11. TomoTherapy Shareholders Approve Accuray Acquisition of TomoTherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... May 20, 2013 /PRNewswire-iReach/ -- It is no secret that ... being overweight or obese gyms and supplement companies are in ... condition is primarily related to dietary issues and a lack ... result of a glandular problem or even a vitamin deficiency. ... vitamin deficiency is a lack of vitamin b12 . ...
(Date:5/20/2013)... 2013   National Community Pharmacists Association (NCPA) ... MBA issued the following statement today regarding a ... D "preferred pharmacy" drug plans , which often ... lowest advertised co-payments: (Logo:  http://photos.prnewswire.com/prnh/20100106/DC33253LOGO ) ... MedPAC , 16 U.S. Senators and ...
(Date:5/20/2013)... 20, 2013 /PRNewswire-iReach/ -- Today at American Society ... Christine Ginocchio discussed Specific Technologies blood ... identification of microorganisms producing bloodstream infection. Dr. Ginocchio ... the Division of Infectious Disease Diagnostics at North ... non-sectarian health system. (Photo: http://photos.prnewswire.com/prnh/20130520/CG16829 ...
Breaking Medicine Technology:USB12Shots.com Discusses the Possibility of B12 Shots for Weight Loss 2Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 2Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 3Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 4Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio 2Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio 3
... Savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) today ... treatment-failure gout will be reviewed by the Arthritis Advisory Committee ... March 5, 2009 as required for a drug of a ... to the FDA on October 31, 2008 seeking approval to ...
... Stock to trade under new ticker symbol ,CDXP.OB, LA ... Bulletin Board: DSKA) announced today that it has completed ... a result of the name change, the Over-the-Counter Bulletin ... ticker symbol OTCBB: CDXP.OB.James S. Kuo, M.D., Cordex,s Chief ...
Cached Medicine Technology:Savient Announces FDA's Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients 2Savient Announces FDA's Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients 3Savient Announces FDA's Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients 4Duska Therapeutics Completes Corporate Name Change to Cordex Pharma 2Duska Therapeutics Completes Corporate Name Change to Cordex Pharma 3
(Date:5/21/2013)... Beginning May 21st, 2013, DTP Sales ... 8000, the newest in digital recording technology, to the ... product for anyone looking to get the most from ... 8000 is expected to have revolutionary options and ... voice recorder features and highlights: , ...
(Date:5/21/2013)... Reinberg HealthDay Reporter , , MONDAY, May 20 ... wheel while drowsy run a higher risk of getting ... not catching up on missed sleep on weekends puts ... at night. "This is another challenge to adolescents ... Winston, co-scientific director and founder of the Center for ...
(Date:5/21/2013)... negative effects of poorly controlled asthma symptoms on ... has been confirmed in a new study. ... sleep and school absences are important indicators of ... first to explore the associations between asthma, sleep ... using both objective and subjective measures," said ...
(Date:5/21/2013)... Mexico (PRWEB) May 21, 2013 Barbara ... for Caregivers ” has over 50 years of experience ... the process of losing both her mom and dad ... been serving as a volunteer with the New Mexico ... given her an understanding and insight into the many ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Canadian-based FundRazr ... hot topic. Announced today, FundRazr has accumulated a list ... our $25 Million raised milestone this week. Among them ... that raised over $1 Million from video gamers, on-going ... Julian Assange, as well as Tiger Woods sending underserved ...
Breaking Medicine News(10 mins):Health News:DTP Sales & Service Announces Upcoming Availability Of Philips Pocket Memo 8000 Series 2Health News:Weekend 'Catch-Up' Sleep May Cut Young Drivers' Crash Risk 2Health News:Asthma symptoms impair sleep quality and school performance in children 2Health News:International Book Release on Alzheimer’s Care-giving by Barbara Michels “The Alzheimer’s Journey…A Practical Perspective for Caregivers 2Health News:International Book Release on Alzheimer’s Care-giving by Barbara Michels “The Alzheimer’s Journey…A Practical Perspective for Caregivers 3Health News:International Book Release on Alzheimer’s Care-giving by Barbara Michels “The Alzheimer’s Journey…A Practical Perspective for Caregivers 4
... Nev., June 20 Bob Hamilton was named Vice,President ... comes to,Hamilton Medical with a financial background and strong ... Smith Barney,Citigroup Private Bank, Vangaurd and Janus Funds, just ... financial analysis, Hamilton Medical is,looking forward to great things ...
... -- The Damon Runyon Cancer Research Foundation named ... May 2008 Clinical Investigator Award Committee review. ... outstanding early career physician-scientists conducting patient-oriented cancer research ... the nation,s leading scientists and clinicians. Each ...
... American College of Physicians (ACP) today commended the Medicare ... importance of primary care in a well-functioning health-care delivery ... ACP commended MedPAC in a letter to Glen D. ... that advises the U.S. Congress on issues affecting the ...
... about test that has no direct evidence of benefit ... may help reduce lung cancer deaths among current and former ... smoking-related causes, a new study reports. , Researchers ... Minn., entered data from 1,520 current and former smokers who ...
... Blockbusters are not,discovered, they are built! To build ... wisely. The recipe for success continues,to evolve for ... allocation processes that enable them to identify early,winners ... paper "Launching a Blockbuster: The Making,and Marketing of ...
... USAID to Invest US $50 Million over a ... Planning, RESEARCH TRIANGLE PARK, N.C., June 20 ... announced that Family,Health International (FHI) -- a global ... major family planning research project known as,PROGRESS (Program ...
Cached Medicine News:Health News:Damon Runyon Cancer Research Foundation awards $2.25M to 5 top young clinical investigators 2Health News:Damon Runyon Cancer Research Foundation awards $2.25M to 5 top young clinical investigators 3Health News:American College of Physicians commends MedPAC June 2008 report to Congress 2Health News:American College of Physicians commends MedPAC June 2008 report to Congress 3Health News:CT Screens for Lung Cancer Not a Cure-All 2Health News:Family Health International Awarded USAID 'Progress' Project to Improve Family Planning and Reproductive Health Programs in Developing Countries 2Health News:Family Health International Awarded USAID 'Progress' Project to Improve Family Planning and Reproductive Health Programs in Developing Countries 3
... is a state-of-the-art hair reduction and ... specially designed for use within a ... features and economy in a single ... treatment of unwanted hair, photo rejuvenation ...
... perfect mix of powerful, versatile, and innovative ... Palomar StarLux® Pulsed Light and Laser System.,With ... compact base unit so theres no ... treatments., You can choose among Laser, Intense ...
Perfect for physicians who prefer a Heavier and Longer tubing, permitting them maximum access around the OR table. 12 feet in length Sizes availabe to fit any vacuum canisters...
... Pump provides optimum flow rate ... Operates on any voltage worldwide. ... safety Interlock and easy load ... Double Spike Tubing, Dual Pneumatic ...
Medicine Products: